BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19382398)

  • 1. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
    Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
    Langer SW; Thougaard AV; Sehested M; Jensen PB
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
    Kane RC; McGuinn WD; Dagher R; Justice R; Pazdur R
    Oncologist; 2008 Apr; 13(4):445-50. PubMed ID: 18448560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dexrazoxane in anthracycline induced cardiotoxicity and extravasation].
    Goey AK; Schellens JH; Beijnen JH; Huitema AD
    Ned Tijdschr Geneeskd; 2010; 154():A1155. PubMed ID: 20619024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of dexrazoxane for the prevention of anthracycline extravasation injury.
    Hasinoff BB
    Expert Opin Investig Drugs; 2008 Feb; 17(2):217-23. PubMed ID: 18230055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
    Tyson AM; Gay WE
    Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of anthracycline extravasation injuries.
    Reeves D
    Ann Pharmacother; 2007 Jul; 41(7):1238-42. PubMed ID: 17550954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of anthracycline extravasation with dexrazoxane -- clinical experience.
    Frost A; Gmehling D; Azemar M; Unger C; Mross K
    Onkologie; 2006 Jul; 29(7):314-8. PubMed ID: 16874015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin.
    Conde-Estévez D; Saumell S; Salar A; Mateu-de Antonio J
    Anticancer Drugs; 2010 Sep; 21(8):790-4. PubMed ID: 20671512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity.
    Jones RL
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1311-7. PubMed ID: 19018683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexrazoxane for anthracycline extravasation.
    Langer SW
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1081-8. PubMed ID: 18028016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical nurse specialist and evidence-based practice: managing anthracycline extravasation.
    Hooke MC
    J Pediatr Oncol Nurs; 2005; 22(5):261-4. PubMed ID: 16079361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.
    Mouridsen HT; Langer SW; Buter J; Eidtmann H; Rosti G; de Wit M; Knoblauch P; Rasmussen A; Dahlstrøm K; Jensen PB; Giaccone G
    Ann Oncol; 2007 Mar; 18(3):546-50. PubMed ID: 17185744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Other uses of dexrazoxane: Savene, the first proven antidote against anthracycline extravasation injuries.
    Langer SW; Jensen PB; Sehested M
    Cardiovasc Toxicol; 2007; 7(2):151-3. PubMed ID: 17652821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Totect: a new agent for treating anthracycline extravasation.
    Schulmeister L
    Clin J Oncol Nurs; 2007 Jun; 11(3):387-95. PubMed ID: 17623623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice.
    Muthuramalingam S; Gale J; Bradbury J
    Int J Clin Pract; 2013 Mar; 67(3):244-9. PubMed ID: 23409691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexrazoxane: a second look. Prevention of anthracycline cardiotoxicity: useful for some patients.
    Prescrire Int; 2008 Oct; 17(97):195. PubMed ID: 19534047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A murine experimental anthracycline extravasation model: pathology and study of the involvement of topoisomerase II alpha and iron in the mechanism of tissue damage.
    Thougaard AV; Langer SW; Hainau B; Grauslund M; Juhl BR; Jensen PB; Sehested M
    Toxicology; 2010 Feb; 269(1):67-72. PubMed ID: 20079798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexrazoxane in anthracycline extravasation.
    Langer SW; Sehested M; Jensen PB; Buter J; Giaccone G
    J Clin Oncol; 2000 Aug; 18(16):3064. PubMed ID: 10944144
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of anthracycline extravasation with dexrazoxane.
    Langer SW; Sehested M; Jensen PB
    Clin Cancer Res; 2000 Sep; 6(9):3680-6. PubMed ID: 10999761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.